搜尋結果
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 2 日前In a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some ...
Next-Gen AI Integrates Logic And Learning: 5 Things To Know
Forbes· 2 日前Neuro-symbolic AI represents the next major advancement in artificial intelligence by combining ...
Protecting Public Officials: Impact Of Judicial Privacy Laws On Background Checks
Forbes· 2 日前In response to rising violence and threats against public officials, state legislatures across ...
Top Meme Coins By Market Capitalization 2024
Forbes· 5 日前The Forbes Advisor editorial team is independent and objective. To help support our reporting ...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 6 日前Pembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the ...